IQWIG
Eisai “cannot understand” German agency’s recommendation to reject Halaven
September 6, 2016Manufacturing and Production, Research and Development Eisai, Germany, Halaven, IQWIG, german
Eisai has issued a statement to declare their “bewilderment” following a decision from the German Institute for Quality and Efficiency …
Germany focus: strength with control
February 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMNOG, EFPIA, Germany, IQWIG, NHS, NICE
Germany is the biggest pharmaceutical market in Europe and one of the biggest in the world, but new systems and …
Germany to cut drug prices by 2 billion euro
November 12, 2010Sales and Marketing Cornelia Yzer, GKV-Spitzenverband, Germany, IQWIG, Philipp Rosler, VFA, health insurers, healthcare spending, innovative medicines
The lower house of the German Parliament has passed a new law to control the cost of new prescription medicines. …
Watchdog resignation forced ‘to appease pharma’
September 6, 2010Sales and Marketing Germany, IQWIG
The head of Germany’s medicines cost-effectiveness watchdog was forced to resign because he was a vocal critic of the pharma …
German price cuts denounced by industry
March 30, 2010Sales and Marketing Germany, IQWIG
Pharma industry organisations have reacted angrily to new government plans in Germany which would enforce mandatory price reductions one year …
EU should require all trials to be registered, says IQWiG
December 1, 2009Sales and Marketing Germany, IQWIG, health economics, hta
Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) has said that registration and publication of all clinical trials …
The Pharmafocus Interview: Elmar Schnee
January 6, 2009Sales and Marketing EU, Germany, IQWIG, Merck Serono, cost-effectiveness
Germany's Merck has the kind of business model that investors warm to during times of recession. The company is the …
